Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Serine Endopeptidases | 49 | 2006 | 146 | 3.420 |
Why?
|
Granzymes | 67 | 2017 | 94 | 3.380 |
Why?
|
Perforin | 36 | 2014 | 55 | 2.360 |
Why?
|
Apoptosis | 43 | 2015 | 1752 | 2.310 |
Why?
|
T-Lymphocytes, Cytotoxic | 26 | 2015 | 321 | 1.540 |
Why?
|
Membrane Glycoproteins | 25 | 2005 | 438 | 1.520 |
Why?
|
Cytoplasmic Granules | 15 | 2009 | 99 | 1.510 |
Why?
|
Cell Membrane | 13 | 2014 | 687 | 1.320 |
Why?
|
Cytotoxicity, Immunologic | 29 | 2009 | 217 | 1.210 |
Why?
|
Killer Cells, Natural | 24 | 2014 | 279 | 1.100 |
Why?
|
Caspases | 18 | 2009 | 158 | 0.810 |
Why?
|
Pore Forming Cytotoxic Proteins | 28 | 2015 | 54 | 0.790 |
Why?
|
Jurkat Cells | 22 | 2014 | 81 | 0.760 |
Why?
|
Cell Membrane Permeability | 6 | 2014 | 120 | 0.640 |
Why?
|
Proteoglycans | 8 | 2005 | 125 | 0.590 |
Why?
|
Flow Cytometry | 12 | 2005 | 704 | 0.470 |
Why?
|
Lymphocytes | 6 | 2004 | 479 | 0.460 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 103 | 0.430 |
Why?
|
Interleukin-6 | 4 | 2008 | 272 | 0.430 |
Why?
|
Mitochondria | 7 | 2015 | 599 | 0.410 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2017 | 709 | 0.390 |
Why?
|
Cysteine Endopeptidases | 7 | 2006 | 87 | 0.380 |
Why?
|
Phosphatidylserines | 1 | 2011 | 21 | 0.380 |
Why?
|
Arthritis, Rheumatoid | 10 | 2017 | 177 | 0.360 |
Why?
|
Interleukin-2 | 9 | 1993 | 244 | 0.350 |
Why?
|
Interleukin-1beta | 2 | 2011 | 85 | 0.320 |
Why?
|
Caspase 3 | 13 | 2015 | 164 | 0.320 |
Why?
|
Killer Cells, Lymphokine-Activated | 7 | 2004 | 27 | 0.300 |
Why?
|
Lymphocyte Activation | 13 | 2004 | 788 | 0.300 |
Why?
|
Fibroblasts | 7 | 2015 | 767 | 0.290 |
Why?
|
Leukocytes, Mononuclear | 2 | 2008 | 206 | 0.290 |
Why?
|
Humans | 101 | 2014 | 92255 | 0.270 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2012 | 626 | 0.270 |
Why?
|
Cytokines | 3 | 2014 | 842 | 0.260 |
Why?
|
Enzyme Precursors | 3 | 2003 | 21 | 0.260 |
Why?
|
Extracellular Space | 3 | 2011 | 86 | 0.260 |
Why?
|
Endocytosis | 5 | 2011 | 185 | 0.250 |
Why?
|
Exocytosis | 5 | 2011 | 110 | 0.250 |
Why?
|
Cell Death | 5 | 2009 | 268 | 0.240 |
Why?
|
HeLa Cells | 8 | 2011 | 518 | 0.240 |
Why?
|
Tumor Cells, Cultured | 19 | 2002 | 1052 | 0.240 |
Why?
|
T-Lymphocytes | 5 | 2004 | 1279 | 0.240 |
Why?
|
Lupus Erythematosus, Systemic | 9 | 1990 | 213 | 0.230 |
Why?
|
Animals | 40 | 2017 | 28076 | 0.230 |
Why?
|
Mice | 26 | 2017 | 12169 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 4 | 2015 | 679 | 0.210 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2009 | 54 | 0.210 |
Why?
|
Lipid Bilayers | 3 | 2014 | 140 | 0.210 |
Why?
|
Lymphocytic choriomeningitis virus | 3 | 2012 | 14 | 0.210 |
Why?
|
Neutrophils | 1 | 2004 | 323 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 4 | 2008 | 209 | 0.200 |
Why?
|
Serpins | 4 | 2006 | 32 | 0.200 |
Why?
|
Arenaviridae Infections | 2 | 2012 | 4 | 0.190 |
Why?
|
Membrane Proteins | 5 | 2015 | 1246 | 0.190 |
Why?
|
Macrophages | 5 | 2014 | 601 | 0.190 |
Why?
|
Hydrogen-Ion Concentration | 4 | 2010 | 502 | 0.180 |
Why?
|
Cell Line | 14 | 2015 | 2527 | 0.180 |
Why?
|
Monocytes | 3 | 2013 | 223 | 0.180 |
Why?
|
Enzyme Activation | 11 | 2008 | 701 | 0.180 |
Why?
|
fas Receptor | 7 | 2004 | 78 | 0.180 |
Why?
|
Glycosaminoglycans | 2 | 2005 | 47 | 0.170 |
Why?
|
Carrier Proteins | 5 | 2004 | 682 | 0.170 |
Why?
|
Rosette Formation | 5 | 1983 | 34 | 0.160 |
Why?
|
Models, Biological | 8 | 2011 | 1784 | 0.160 |
Why?
|
Calcium | 5 | 2011 | 1185 | 0.150 |
Why?
|
Cells, Cultured | 15 | 2014 | 2911 | 0.150 |
Why?
|
Signal Transduction | 8 | 2009 | 3510 | 0.150 |
Why?
|
Cartilage | 2 | 2001 | 117 | 0.150 |
Why?
|
Antibodies, Monoclonal | 11 | 2010 | 1404 | 0.150 |
Why?
|
Substrate Specificity | 6 | 2008 | 362 | 0.150 |
Why?
|
Cattle | 5 | 2011 | 380 | 0.150 |
Why?
|
Electrophoresis, Agar Gel | 2 | 2002 | 49 | 0.150 |
Why?
|
Chromatography, Affinity | 2 | 2000 | 81 | 0.150 |
Why?
|
Peptide Fragments | 3 | 2010 | 467 | 0.140 |
Why?
|
Secretory Vesicles | 2 | 2011 | 43 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 7 | 2005 | 375 | 0.140 |
Why?
|
Research Design | 1 | 2001 | 599 | 0.140 |
Why?
|
Interleukin-8 | 2 | 1996 | 86 | 0.140 |
Why?
|
Arthritis, Experimental | 1 | 2017 | 26 | 0.130 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2004 | 269 | 0.130 |
Why?
|
Vesicular Transport Proteins | 4 | 2005 | 66 | 0.130 |
Why?
|
Protein Binding | 6 | 2014 | 1515 | 0.130 |
Why?
|
Immunoglobulin G | 8 | 1997 | 475 | 0.130 |
Why?
|
Membrane Lipids | 2 | 2014 | 41 | 0.130 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 3 | 1984 | 22 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2015 | 203 | 0.120 |
Why?
|
Necrosis | 2 | 2014 | 209 | 0.120 |
Why?
|
Protein Conformation | 4 | 2012 | 905 | 0.120 |
Why?
|
Cell Nucleus | 6 | 2001 | 612 | 0.120 |
Why?
|
Protein Transport | 2 | 2014 | 431 | 0.120 |
Why?
|
Osteogenesis | 1 | 2017 | 270 | 0.120 |
Why?
|
Esterases | 1 | 1994 | 13 | 0.120 |
Why?
|
Carboxypeptidases | 1 | 1994 | 35 | 0.120 |
Why?
|
Gene Knockdown Techniques | 3 | 2013 | 254 | 0.120 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2010 | 318 | 0.110 |
Why?
|
Caspase 1 | 3 | 2006 | 20 | 0.110 |
Why?
|
Cell Line, Tumor | 7 | 2010 | 2670 | 0.110 |
Why?
|
Amino Acid Sequence | 8 | 2012 | 2082 | 0.110 |
Why?
|
Kinetics | 10 | 2002 | 1550 | 0.110 |
Why?
|
Cell Separation | 3 | 1984 | 201 | 0.110 |
Why?
|
Epitopes | 2 | 2011 | 254 | 0.110 |
Why?
|
Autoantibodies | 3 | 1990 | 276 | 0.110 |
Why?
|
B-Lymphocytes | 3 | 1987 | 754 | 0.110 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 2 | 2004 | 14 | 0.110 |
Why?
|
Receptor, IGF Type 2 | 2 | 2004 | 6 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2014 | 124 | 0.110 |
Why?
|
Cell Adhesion | 4 | 2008 | 431 | 0.110 |
Why?
|
Propidium | 2 | 2011 | 6 | 0.110 |
Why?
|
Caspase 7 | 4 | 2003 | 15 | 0.110 |
Why?
|
DNA Fragmentation | 6 | 2004 | 63 | 0.110 |
Why?
|
Models, Molecular | 3 | 2014 | 1338 | 0.110 |
Why?
|
Models, Immunological | 2 | 2004 | 84 | 0.110 |
Why?
|
Glycoproteins | 1 | 1994 | 236 | 0.110 |
Why?
|
Bacteremia | 1 | 2014 | 104 | 0.110 |
Why?
|
Molecular Sequence Data | 8 | 2012 | 3034 | 0.110 |
Why?
|
Extracellular Matrix Proteins | 1 | 1993 | 129 | 0.100 |
Why?
|
Hydrolysis | 4 | 2005 | 144 | 0.100 |
Why?
|
Adenoviridae | 4 | 2008 | 349 | 0.100 |
Why?
|
Mycobacterium | 1 | 2013 | 19 | 0.100 |
Why?
|
Receptors, Fc | 2 | 1984 | 33 | 0.100 |
Why?
|
Sheep | 2 | 2011 | 250 | 0.100 |
Why?
|
Cytotoxins | 1 | 2012 | 16 | 0.100 |
Why?
|
Complement Membrane Attack Complex | 1 | 2012 | 21 | 0.100 |
Why?
|
Inflammation | 2 | 2009 | 1023 | 0.100 |
Why?
|
Receptors, Interleukin-1 | 1 | 2012 | 11 | 0.100 |
Why?
|
Poloxalene | 1 | 1992 | 8 | 0.100 |
Why?
|
Serine Proteinase Inhibitors | 4 | 2003 | 28 | 0.100 |
Why?
|
Annexin A5 | 1 | 2011 | 20 | 0.090 |
Why?
|
Thrombin | 3 | 1996 | 60 | 0.090 |
Why?
|
Cytoskeleton | 2 | 2010 | 202 | 0.090 |
Why?
|
Ions | 1 | 2011 | 76 | 0.090 |
Why?
|
beta-Endorphin | 3 | 1987 | 11 | 0.090 |
Why?
|
Antibody Specificity | 4 | 1998 | 131 | 0.090 |
Why?
|
Polyradiculoneuropathy | 2 | 1981 | 8 | 0.090 |
Why?
|
Recombinant Proteins | 8 | 2011 | 1020 | 0.090 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2013 | 219 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 283 | 0.090 |
Why?
|
Extracellular Matrix | 3 | 2005 | 249 | 0.090 |
Why?
|
Immunity, Innate | 2 | 2011 | 439 | 0.090 |
Why?
|
Blotting, Western | 4 | 2004 | 800 | 0.090 |
Why?
|
DNA Damage | 3 | 2009 | 381 | 0.090 |
Why?
|
Gelsolin | 1 | 2010 | 11 | 0.090 |
Why?
|
Biological Transport | 5 | 2005 | 410 | 0.090 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2010 | 30 | 0.090 |
Why?
|
RNA, Small Cytoplasmic | 1 | 1990 | 2 | 0.090 |
Why?
|
Mice, Inbred C57BL | 7 | 2017 | 3369 | 0.080 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 1990 | 20 | 0.080 |
Why?
|
Time Factors | 3 | 2011 | 5435 | 0.080 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2001 | 97 | 0.080 |
Why?
|
Cytotoxicity Tests, Immunologic | 5 | 1996 | 43 | 0.080 |
Why?
|
Mitogens | 2 | 1987 | 62 | 0.080 |
Why?
|
Cholesterol | 1 | 2011 | 361 | 0.080 |
Why?
|
K562 Cells | 3 | 2009 | 47 | 0.080 |
Why?
|
U937 Cells | 1 | 2008 | 32 | 0.080 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 1989 | 48 | 0.080 |
Why?
|
Chlamydia trachomatis | 1 | 2008 | 15 | 0.080 |
Why?
|
Interferon-gamma | 2 | 2008 | 453 | 0.080 |
Why?
|
Unilamellar Liposomes | 1 | 2008 | 5 | 0.080 |
Why?
|
Chlamydia Infections | 1 | 2008 | 32 | 0.070 |
Why?
|
Uveal Neoplasms | 1 | 2008 | 11 | 0.070 |
Why?
|
Streptolysins | 3 | 2008 | 5 | 0.070 |
Why?
|
Tubulin | 1 | 2008 | 60 | 0.070 |
Why?
|
Deltaretrovirus | 1 | 1987 | 2 | 0.070 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1987 | 73 | 0.070 |
Why?
|
Receptors, Interleukin-2 | 1 | 1988 | 68 | 0.070 |
Why?
|
Surface Plasmon Resonance | 2 | 2010 | 47 | 0.070 |
Why?
|
Microtubules | 1 | 2008 | 129 | 0.070 |
Why?
|
Mice, Knockout | 6 | 2012 | 2088 | 0.070 |
Why?
|
Endorphins | 2 | 1984 | 13 | 0.070 |
Why?
|
Antilymphocyte Serum | 4 | 1983 | 70 | 0.070 |
Why?
|
Immunophenotyping | 1 | 2008 | 221 | 0.070 |
Why?
|
DNA Repair | 1 | 2009 | 366 | 0.070 |
Why?
|
Permeability | 2 | 2005 | 139 | 0.070 |
Why?
|
Models, Chemical | 1 | 2008 | 181 | 0.070 |
Why?
|
Cytosol | 4 | 1999 | 195 | 0.070 |
Why?
|
In Vitro Techniques | 5 | 1996 | 997 | 0.070 |
Why?
|
Cell Survival | 4 | 2004 | 1012 | 0.070 |
Why?
|
Phylogeny | 1 | 2012 | 1228 | 0.070 |
Why?
|
Lipids | 1 | 2008 | 278 | 0.070 |
Why?
|
Ultracentrifugation | 3 | 2002 | 42 | 0.070 |
Why?
|
Lymphokines | 1 | 1986 | 75 | 0.060 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 3 | 2015 | 43 | 0.060 |
Why?
|
Protein Structure, Tertiary | 3 | 2014 | 743 | 0.060 |
Why?
|
Scattering, Radiation | 2 | 2002 | 118 | 0.060 |
Why?
|
Biotinylation | 2 | 2002 | 42 | 0.060 |
Why?
|
Vitronectin | 1 | 2005 | 6 | 0.060 |
Why?
|
Microscopy, Fluorescence | 4 | 2011 | 442 | 0.060 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2005 | 21 | 0.060 |
Why?
|
Oligopeptides | 2 | 1998 | 190 | 0.060 |
Why?
|
Transfection | 6 | 2004 | 914 | 0.060 |
Why?
|
Biological Assay | 1 | 2005 | 81 | 0.060 |
Why?
|
WT1 Proteins | 1 | 2004 | 20 | 0.060 |
Why?
|
Epithelium | 2 | 1996 | 324 | 0.060 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2005 | 89 | 0.060 |
Why?
|
Laminin | 1 | 2005 | 93 | 0.060 |
Why?
|
Viruses | 1 | 2005 | 78 | 0.060 |
Why?
|
Biomarkers | 1 | 2011 | 1846 | 0.060 |
Why?
|
Fibronectins | 1 | 2005 | 102 | 0.060 |
Why?
|
Membrane Potentials | 2 | 2003 | 439 | 0.060 |
Why?
|
Arthritis, Juvenile | 2 | 1981 | 32 | 0.060 |
Why?
|
Liver | 2 | 2014 | 1227 | 0.060 |
Why?
|
Breast Neoplasms | 5 | 2004 | 3053 | 0.060 |
Why?
|
Aging | 2 | 1990 | 735 | 0.050 |
Why?
|
Membrane Microdomains | 1 | 2004 | 54 | 0.050 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2003 | 36 | 0.050 |
Why?
|
Melanoma | 1 | 2008 | 481 | 0.050 |
Why?
|
Centrifugation, Density Gradient | 3 | 2000 | 112 | 0.050 |
Why?
|
Caspase 9 | 5 | 2004 | 49 | 0.050 |
Why?
|
Immunologic Memory | 1 | 2004 | 176 | 0.050 |
Why?
|
bcl-2-Associated X Protein | 1 | 2003 | 55 | 0.050 |
Why?
|
Doxorubicin | 2 | 2001 | 296 | 0.050 |
Why?
|
Sepharose | 1 | 2002 | 14 | 0.050 |
Why?
|
Electrophoresis, Capillary | 1 | 2002 | 11 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2001 | 111 | 0.050 |
Why?
|
Spleen | 3 | 2014 | 434 | 0.050 |
Why?
|
Lysosomes | 1 | 2003 | 117 | 0.050 |
Why?
|
Cytomegalovirus | 1 | 2003 | 85 | 0.050 |
Why?
|
Chondroitin Sulfates | 1 | 2002 | 43 | 0.050 |
Why?
|
Synovial Fluid | 2 | 1999 | 10 | 0.050 |
Why?
|
Lasers | 1 | 2002 | 106 | 0.050 |
Why?
|
Biophysical Phenomena | 1 | 2002 | 124 | 0.050 |
Why?
|
Biophysics | 1 | 2002 | 154 | 0.050 |
Why?
|
Endosomes | 2 | 1999 | 82 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 1940 | 0.050 |
Why?
|
Microscopy, Confocal | 5 | 2004 | 284 | 0.050 |
Why?
|
Macromolecular Substances | 2 | 1999 | 177 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 3 | 1999 | 408 | 0.050 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1982 | 19 | 0.050 |
Why?
|
HIV-1 | 2 | 2000 | 163 | 0.050 |
Why?
|
Homeostasis | 1 | 2004 | 450 | 0.050 |
Why?
|
Caspase Inhibitors | 1 | 2001 | 33 | 0.050 |
Why?
|
Cardiolipins | 3 | 1991 | 17 | 0.050 |
Why?
|
Biosensing Techniques | 1 | 2002 | 76 | 0.050 |
Why?
|
Viral Proteins | 1 | 2003 | 303 | 0.050 |
Why?
|
Nuclear Envelope | 2 | 1998 | 39 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 3 | 1990 | 324 | 0.050 |
Why?
|
Light | 1 | 2002 | 294 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2004 | 333 | 0.050 |
Why?
|
Viral Envelope Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
Intracellular Fluid | 1 | 2001 | 34 | 0.050 |
Why?
|
Fas Ligand Protein | 4 | 2002 | 50 | 0.050 |
Why?
|
Caspase 8 | 4 | 2004 | 35 | 0.050 |
Why?
|
Synovial Membrane | 1 | 2001 | 30 | 0.040 |
Why?
|
Nephrosis, Lipoid | 1 | 1980 | 6 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2001 | 104 | 0.040 |
Why?
|
Glucose | 1 | 2004 | 684 | 0.040 |
Why?
|
Bcl-2-Like Protein 11 | 2 | 2015 | 25 | 0.040 |
Why?
|
Hemolysis | 2 | 2000 | 62 | 0.040 |
Why?
|
Simplexvirus | 1 | 2001 | 151 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2001 | 173 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2004 | 547 | 0.040 |
Why?
|
Specimen Handling | 1 | 2001 | 103 | 0.040 |
Why?
|
Precipitin Tests | 2 | 2004 | 111 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2004 | 340 | 0.040 |
Why?
|
Drug Resistance | 1 | 2001 | 235 | 0.040 |
Why?
|
Naphthoquinones | 1 | 2000 | 5 | 0.040 |
Why?
|
Etoposide | 1 | 2001 | 205 | 0.040 |
Why?
|
Cryoelectron Microscopy | 2 | 2011 | 105 | 0.040 |
Why?
|
NF-kappa B | 1 | 2003 | 470 | 0.040 |
Why?
|
Hemolysin Proteins | 1 | 1999 | 34 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2000 | 72 | 0.040 |
Why?
|
Rheumatoid Factor | 2 | 1997 | 26 | 0.040 |
Why?
|
Penicillamine | 1 | 1979 | 12 | 0.040 |
Why?
|
Receptors, Thrombin | 2 | 1996 | 3 | 0.040 |
Why?
|
Bacterial Toxins | 1 | 1999 | 115 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 560 | 0.040 |
Why?
|
Gene Deletion | 2 | 2015 | 351 | 0.040 |
Why?
|
Heat-Shock Proteins | 1 | 1999 | 183 | 0.040 |
Why?
|
HIV Infections | 3 | 2003 | 870 | 0.040 |
Why?
|
Cell Fractionation | 2 | 2000 | 71 | 0.040 |
Why?
|
Myasthenia Gravis | 1 | 1979 | 84 | 0.040 |
Why?
|
Software | 1 | 2002 | 673 | 0.040 |
Why?
|
Organophosphonates | 1 | 1998 | 52 | 0.040 |
Why?
|
Bacterial Proteins | 4 | 2008 | 907 | 0.040 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 1996 | 116 | 0.040 |
Why?
|
Lymphocyte Subsets | 1 | 1998 | 66 | 0.040 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1997 | 16 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2001 | 342 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 1998 | 298 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1998 | 223 | 0.040 |
Why?
|
Subcellular Fractions | 2 | 2010 | 95 | 0.040 |
Why?
|
Pregnancy Complications | 1 | 1980 | 345 | 0.040 |
Why?
|
Culture Media | 2 | 1989 | 149 | 0.040 |
Why?
|
Amino Acids | 1 | 1998 | 255 | 0.030 |
Why?
|
Rabbits | 2 | 2000 | 643 | 0.030 |
Why?
|
Cobalt | 1 | 1996 | 31 | 0.030 |
Why?
|
Cell-Free System | 1 | 1996 | 51 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2000 | 463 | 0.030 |
Why?
|
Helminth Proteins | 1 | 1996 | 12 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2001 | 582 | 0.030 |
Why?
|
DNA | 2 | 1994 | 1314 | 0.030 |
Why?
|
Connective Tissue Diseases | 1 | 1997 | 70 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1998 | 388 | 0.030 |
Why?
|
RNA, Viral | 1 | 1997 | 323 | 0.030 |
Why?
|
Binding Sites | 3 | 2006 | 1132 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 1998 | 202 | 0.030 |
Why?
|
Female | 15 | 2017 | 47848 | 0.030 |
Why?
|
Mice, Inbred BALB C | 3 | 2005 | 1110 | 0.030 |
Why?
|
Cell Compartmentation | 2 | 2010 | 70 | 0.030 |
Why?
|
Cathepsin A | 1 | 1994 | 2 | 0.030 |
Why?
|
Calcimycin | 1 | 1994 | 33 | 0.030 |
Why?
|
Colicins | 1 | 2014 | 1 | 0.030 |
Why?
|
Chymotrypsin | 1 | 1994 | 28 | 0.030 |
Why?
|
Melitten | 1 | 2014 | 9 | 0.030 |
Why?
|
Cathepsins | 1 | 1994 | 21 | 0.030 |
Why?
|
Antibodies | 2 | 2001 | 352 | 0.030 |
Why?
|
Immunotherapy | 2 | 2015 | 723 | 0.030 |
Why?
|
RNA, Messenger | 3 | 2010 | 2041 | 0.030 |
Why?
|
Brucella | 1 | 2014 | 4 | 0.030 |
Why?
|
Down-Regulation | 2 | 2008 | 523 | 0.030 |
Why?
|
Male | 14 | 2004 | 43886 | 0.030 |
Why?
|
Proteolysis | 1 | 2015 | 121 | 0.030 |
Why?
|
Hypotonic Solutions | 1 | 1993 | 8 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1993 | 33 | 0.030 |
Why?
|
Aggrecans | 1 | 1993 | 43 | 0.030 |
Why?
|
Detergents | 1 | 1993 | 34 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 333 | 0.030 |
Why?
|
Up-Regulation | 2 | 2008 | 731 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 1993 | 87 | 0.030 |
Why?
|
Rats | 4 | 2002 | 4077 | 0.030 |
Why?
|
Herpesvirus 4, Human | 2 | 1998 | 122 | 0.030 |
Why?
|
Neutralization Tests | 1 | 2013 | 80 | 0.030 |
Why?
|
Interferon Type I | 2 | 1984 | 191 | 0.030 |
Why?
|
Adult | 13 | 1999 | 27520 | 0.030 |
Why?
|
Apicomplexa | 1 | 2012 | 5 | 0.030 |
Why?
|
Skin | 1 | 1996 | 592 | 0.030 |
Why?
|
Polymerization | 1 | 2012 | 34 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2010 | 1171 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 893 | 0.020 |
Why?
|
Splenomegaly | 1 | 2012 | 28 | 0.020 |
Why?
|
Retinal Vein Occlusion | 2 | 1989 | 8 | 0.020 |
Why?
|
Hepatitis | 1 | 2012 | 35 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2013 | 108 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1992 | 101 | 0.020 |
Why?
|
Delayed-Action Preparations | 1 | 1992 | 111 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2012 | 358 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 1992 | 309 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 1996 | 735 | 0.020 |
Why?
|
Nasal Septum | 1 | 1991 | 27 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2005 | 419 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 1992 | 67 | 0.020 |
Why?
|
Chondrosarcoma | 1 | 1991 | 51 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 1991 | 100 | 0.020 |
Why?
|
Receptors, Purinergic P2X7 | 1 | 2011 | 9 | 0.020 |
Why?
|
Receptors, IgG | 2 | 2001 | 56 | 0.020 |
Why?
|
Rats, Inbred F344 | 2 | 2002 | 154 | 0.020 |
Why?
|
Epithelial Cells | 1 | 1995 | 702 | 0.020 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2011 | 13 | 0.020 |
Why?
|
Cartilage, Articular | 1 | 1991 | 68 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2005 | 1608 | 0.020 |
Why?
|
Bone Marrow Cells | 2 | 2004 | 264 | 0.020 |
Why?
|
Peptides | 2 | 2004 | 656 | 0.020 |
Why?
|
Egtazic Acid | 2 | 2004 | 33 | 0.020 |
Why?
|
Proteins | 1 | 1996 | 804 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 1 | 2010 | 23 | 0.020 |
Why?
|
Host-Pathogen Interactions | 1 | 2013 | 238 | 0.020 |
Why?
|
Intracellular Membranes | 2 | 2001 | 117 | 0.020 |
Why?
|
Cyclophilins | 1 | 2010 | 8 | 0.020 |
Why?
|
Tetracycline | 1 | 2010 | 13 | 0.020 |
Why?
|
Immunodiffusion | 1 | 1990 | 28 | 0.020 |
Why?
|
snRNP Core Proteins | 1 | 1990 | 9 | 0.020 |
Why?
|
Liposomes | 1 | 2010 | 94 | 0.020 |
Why?
|
Sodium Chloride | 1 | 2010 | 88 | 0.020 |
Why?
|
Mixed Connective Tissue Disease | 1 | 1990 | 6 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2011 | 162 | 0.020 |
Why?
|
Cytoplasm | 2 | 2003 | 286 | 0.020 |
Why?
|
Cocaine | 1 | 1991 | 77 | 0.020 |
Why?
|
Chromatography, Gel | 2 | 2000 | 103 | 0.020 |
Why?
|
Ribonucleoproteins | 1 | 1990 | 38 | 0.020 |
Why?
|
Virus Replication | 2 | 2003 | 329 | 0.020 |
Why?
|
Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 26 | 0.020 |
Why?
|
Anemia, Pernicious | 1 | 1989 | 2 | 0.020 |
Why?
|
Sudden Infant Death | 1 | 1990 | 27 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1990 | 93 | 0.020 |
Why?
|
Scleroderma, Systemic | 1 | 1990 | 57 | 0.020 |
Why?
|
Lung | 1 | 1996 | 1336 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 1990 | 122 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 129 | 0.020 |
Why?
|
Caspase 10 | 2 | 1998 | 5 | 0.020 |
Why?
|
Autoantigens | 1 | 1990 | 133 | 0.020 |
Why?
|
Plasma | 1 | 1989 | 51 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 339 | 0.020 |
Why?
|
Octoxynol | 1 | 2008 | 8 | 0.020 |
Why?
|
Bacteria | 1 | 2012 | 499 | 0.020 |
Why?
|
Prednisone | 1 | 1989 | 255 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 1988 | 21 | 0.020 |
Why?
|
Prostaglandins E | 1 | 1987 | 19 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2009 | 286 | 0.020 |
Why?
|
Receptors, Opioid | 1 | 1987 | 23 | 0.020 |
Why?
|
Immunity, Cellular | 2 | 1996 | 182 | 0.020 |
Why?
|
Clone Cells | 1 | 2008 | 216 | 0.020 |
Why?
|
Dinoprostone | 1 | 1987 | 72 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2005 | 1809 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2008 | 201 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2001 | 622 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2008 | 277 | 0.020 |
Why?
|
Immunoglobulin M | 3 | 1997 | 163 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 1998 | 2367 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2008 | 229 | 0.020 |
Why?
|
Peptide Mapping | 1 | 2006 | 26 | 0.020 |
Why?
|
DNA Replication | 1 | 1988 | 173 | 0.020 |
Why?
|
Chymases | 2 | 1998 | 10 | 0.020 |
Why?
|
Phenotype | 2 | 1983 | 2502 | 0.020 |
Why?
|
Phospholipids | 1 | 1987 | 112 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 1991 | 424 | 0.020 |
Why?
|
Isocoumarins | 2 | 1997 | 7 | 0.020 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2006 | 97 | 0.020 |
Why?
|
Blood Proteins | 1 | 1987 | 149 | 0.020 |
Why?
|
Coumarins | 2 | 1997 | 14 | 0.020 |
Why?
|
Pyruvates | 1 | 1986 | 11 | 0.020 |
Why?
|
Pyruvic Acid | 1 | 1986 | 12 | 0.020 |
Why?
|
Cell Transformation, Viral | 1 | 1986 | 39 | 0.020 |
Why?
|
Indomethacin | 1 | 1986 | 59 | 0.020 |
Why?
|
Retinal Diseases | 1 | 1987 | 91 | 0.020 |
Why?
|
Binding, Competitive | 2 | 1983 | 146 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2005 | 25 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2008 | 355 | 0.020 |
Why?
|
Salmonella typhimurium | 1 | 1985 | 32 | 0.020 |
Why?
|
Gene Expression | 1 | 2009 | 1318 | 0.020 |
Why?
|
Sulfates | 1 | 2005 | 57 | 0.010 |
Why?
|
Static Electricity | 1 | 2005 | 95 | 0.010 |
Why?
|
CHO Cells | 1 | 2005 | 190 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2012 | 2459 | 0.010 |
Why?
|
Chromium | 1 | 2004 | 17 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2005 | 112 | 0.010 |
Why?
|
Macrolides | 1 | 2004 | 31 | 0.010 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2004 | 9 | 0.010 |
Why?
|
Genes, MHC Class I | 1 | 2004 | 48 | 0.010 |
Why?
|
Neoplasms | 2 | 2015 | 3120 | 0.010 |
Why?
|
Protein Hydrolysates | 1 | 1984 | 9 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2004 | 100 | 0.010 |
Why?
|
Crosses, Genetic | 1 | 2004 | 171 | 0.010 |
Why?
|
Chromium Radioisotopes | 1 | 2004 | 3 | 0.010 |
Why?
|
Cytochromes c | 1 | 2004 | 28 | 0.010 |
Why?
|
Acidosis | 1 | 1984 | 55 | 0.010 |
Why?
|
Cricetinae | 1 | 2005 | 560 | 0.010 |
Why?
|
Thymidine | 1 | 2004 | 59 | 0.010 |
Why?
|
Acid-Base Equilibrium | 1 | 1984 | 34 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 141 | 0.010 |
Why?
|
Endopeptidases | 1 | 2004 | 118 | 0.010 |
Why?
|
Parenteral Nutrition | 1 | 1984 | 62 | 0.010 |
Why?
|
DNA Primers | 1 | 2004 | 547 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 276 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 284 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1983 | 49 | 0.010 |
Why?
|
Clathrin | 1 | 2003 | 32 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 283 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2004 | 648 | 0.010 |
Why?
|
Lymphoma | 1 | 2004 | 267 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 345 | 0.010 |
Why?
|
Dynamins | 1 | 2003 | 51 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2003 | 371 | 0.010 |
Why?
|
Erythrocytes | 1 | 1983 | 252 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2004 | 365 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 200 | 0.010 |
Why?
|
Myeloma Proteins | 1 | 1982 | 37 | 0.010 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2001 | 8 | 0.010 |
Why?
|
Rats, Wistar | 1 | 2002 | 305 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 394 | 0.010 |
Why?
|
Transcription Factors | 1 | 1990 | 1684 | 0.010 |
Why?
|
Vero Cells | 1 | 2001 | 103 | 0.010 |
Why?
|
Herpesvirus 2, Human | 1 | 2001 | 45 | 0.010 |
Why?
|
Cytochrome c Group | 1 | 2001 | 83 | 0.010 |
Why?
|
Rubidium | 1 | 2001 | 9 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 20 | 0.010 |
Why?
|
Receptors, Transferrin | 1 | 2001 | 12 | 0.010 |
Why?
|
Drug Resistance, Multiple | 1 | 2001 | 19 | 0.010 |
Why?
|
Leukemia, T-Cell | 1 | 2001 | 17 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 1982 | 142 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1981 | 44 | 0.010 |
Why?
|
Metacarpophalangeal Joint | 1 | 2001 | 9 | 0.010 |
Why?
|
Agammaglobulinemia | 1 | 1981 | 20 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2001 | 66 | 0.010 |
Why?
|
Vincristine | 1 | 2001 | 109 | 0.010 |
Why?
|
Fluorescence | 1 | 1981 | 104 | 0.010 |
Why?
|
Sural Nerve | 1 | 1980 | 19 | 0.010 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2001 | 83 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 2332 | 0.010 |
Why?
|
Chondrocytes | 1 | 2001 | 65 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1980 | 78 | 0.010 |
Why?
|
Pyridinium Compounds | 1 | 2000 | 10 | 0.010 |
Why?
|
Benzimidazoles | 1 | 2001 | 109 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2001 | 269 | 0.010 |
Why?
|
alpha-Macroglobulins | 1 | 2000 | 3 | 0.010 |
Why?
|
Antithrombin III | 1 | 2000 | 9 | 0.010 |
Why?
|
Neoplasms, Experimental | 1 | 1982 | 270 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2000 | 81 | 0.010 |
Why?
|
Idoxuridine | 1 | 2000 | 16 | 0.010 |
Why?
|
Leukemia, Experimental | 1 | 2000 | 15 | 0.010 |
Why?
|
Antibody Formation | 1 | 1980 | 174 | 0.010 |
Why?
|
Prognosis | 1 | 2008 | 3863 | 0.010 |
Why?
|
Virion | 1 | 2000 | 60 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2000 | 101 | 0.010 |
Why?
|
Biomarkers, Tumor | 1 | 2008 | 1575 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2000 | 135 | 0.010 |
Why?
|
Fetus | 1 | 1980 | 234 | 0.010 |
Why?
|
Munchausen Syndrome | 1 | 1979 | 2 | 0.010 |
Why?
|
Immunity | 1 | 1980 | 150 | 0.010 |
Why?
|
Hemoglobins | 1 | 2000 | 190 | 0.010 |
Why?
|
Collagen | 1 | 2001 | 300 | 0.010 |
Why?
|
Herpesvirus 1, Human | 1 | 2001 | 245 | 0.010 |
Why?
|
Antigens, CD | 1 | 2001 | 474 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2001 | 275 | 0.010 |
Why?
|
Mouth | 1 | 1979 | 49 | 0.010 |
Why?
|
CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 1998 | 13 | 0.010 |
Why?
|
Cholic Acids | 1 | 1998 | 6 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2000 | 154 | 0.010 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 1998 | 2 | 0.010 |
Why?
|
Gamma Rays | 1 | 1998 | 73 | 0.010 |
Why?
|
Cell Nucleolus | 1 | 1998 | 25 | 0.010 |
Why?
|
Liver Neoplasms, Experimental | 1 | 1998 | 26 | 0.010 |
Why?
|
Trypsin Inhibitors | 1 | 1998 | 6 | 0.010 |
Why?
|
Tryptases | 1 | 1998 | 11 | 0.010 |
Why?
|
Abscess | 1 | 1979 | 95 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1998 | 146 | 0.010 |
Why?
|
Lupus Coagulation Inhibitor | 2 | 1989 | 7 | 0.010 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1998 | 27 | 0.010 |
Why?
|
Microinjections | 1 | 1998 | 71 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2000 | 260 | 0.010 |
Why?
|
Trypsin | 1 | 1998 | 95 | 0.010 |
Why?
|
Dextrans | 1 | 1998 | 78 | 0.010 |
Why?
|
Cell Degranulation | 1 | 1998 | 15 | 0.010 |
Why?
|
Infectious Mononucleosis | 1 | 1998 | 6 | 0.010 |
Why?
|
Blood Coagulation Factors | 2 | 1989 | 20 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 167 | 0.010 |
Why?
|
Drug Interactions | 1 | 1998 | 244 | 0.010 |
Why?
|
Mast Cells | 1 | 1998 | 96 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 1998 | 127 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 146 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2004 | 1591 | 0.010 |
Why?
|
Virus Cultivation | 1 | 1997 | 20 | 0.010 |
Why?
|
Solubility | 1 | 1998 | 186 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 1998 | 319 | 0.010 |
Why?
|
Blood Donors | 1 | 1997 | 23 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1998 | 432 | 0.010 |
Why?
|
Middle Aged | 5 | 1999 | 27041 | 0.010 |
Why?
|
Rheumatic Diseases | 1 | 1997 | 28 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1997 | 88 | 0.010 |
Why?
|
Graft Rejection | 1 | 2003 | 1097 | 0.010 |
Why?
|
Lamins | 1 | 1996 | 6 | 0.010 |
Why?
|
Caspase 6 | 1 | 1996 | 3 | 0.010 |
Why?
|
Staurosporine | 1 | 1996 | 34 | 0.010 |
Why?
|
Regression Analysis | 2 | 1991 | 595 | 0.010 |
Why?
|
Alkaloids | 1 | 1996 | 46 | 0.010 |
Why?
|
Aged | 2 | 1999 | 19943 | 0.010 |
Why?
|
Lamin Type A | 1 | 1996 | 26 | 0.010 |
Why?
|
Phagocytosis | 1 | 1996 | 93 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1996 | 393 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 421 | 0.010 |
Why?
|
Aurintricarboxylic Acid | 1 | 1994 | 1 | 0.010 |
Why?
|
Sulfones | 1 | 1994 | 46 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1994 | 258 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 1998 | 1119 | 0.010 |
Why?
|
Child, Preschool | 1 | 1981 | 3804 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2000 | 860 | 0.010 |
Why?
|
Pregnancy | 1 | 1980 | 3105 | 0.010 |
Why?
|
Child | 2 | 1981 | 7311 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 2012 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2004 | 1770 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2004 | 8720 | 0.010 |
Why?
|
Serum Globulins | 1 | 1991 | 12 | 0.010 |
Why?
|
Mutation | 1 | 2003 | 4226 | 0.010 |
Why?
|
Antibodies, Antinuclear | 1 | 1991 | 87 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 1991 | 62 | 0.010 |
Why?
|
Sclerosis | 1 | 1990 | 30 | 0.010 |
Why?
|
Hypoprothrombinemias | 1 | 1989 | 1 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 1991 | 161 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1989 | 24 | 0.010 |
Why?
|
Aspirin | 1 | 1989 | 163 | 0.000 |
Why?
|
Adolescent | 1 | 1981 | 9491 | 0.000 |
Why?
|
Retinal Artery | 1 | 1987 | 3 | 0.000 |
Why?
|
Arterial Occlusive Diseases | 1 | 1987 | 110 | 0.000 |
Why?
|
Bicarbonates | 1 | 1984 | 58 | 0.000 |
Why?
|
Immune Sera | 1 | 1983 | 52 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1990 | 2511 | 0.000 |
Why?
|
Enkephalin, Methionine | 1 | 1983 | 5 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1983 | 89 | 0.000 |
Why?
|
Infant | 1 | 1990 | 3206 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1997 | 9654 | 0.000 |
Why?
|
Naloxone | 1 | 1983 | 69 | 0.000 |
Why?
|
Thigh | 1 | 1979 | 39 | 0.000 |
Why?
|
Saliva | 1 | 1979 | 126 | 0.000 |
Why?
|
Recurrence | 1 | 1979 | 1181 | 0.000 |
Why?
|